| Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi |
NCT00830102: Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Concurrently or Alone in Asthma Patients |
|
|
| Completed | 2 | 64 | Europe | fluticasone propionate, formoterol fumarate, FlutiForm | SkyePharma AG | Asthma | 01/05 | 01/05 | | |
NCT00734292: Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of FlutiForm HFA pMDI in Adult Subjects With Mild to Moderate Asthma |
|
|
| Completed | 2 | 39 | US | fluticasone propionate, formoterol fumarate, FlutiForm | SkyePharma AG, Abbott | Mild to Moderate Asthma | 09/08 | 10/08 | | |
NCT00995800 / 2009-009873-87: Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate Asthma |
|
|
| Completed | 2 | 46 | Europe | Fluticasone propionate / Formoterol fumarate | Mundipharma Research Limited | Asthma | 07/10 | 07/10 | | |
NCT02063139 / 2013-004719-32: Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years. |
|
|
| Completed | 2 | 48 | Europe | Flutiform 50/5 ug (2 puffs bid) pMDI, Fluticasone 50 ug (2puffs bid) pMDI, Beclometasone Autohaler 50 ug (2 puffs bid) | Mundipharma Research Limited | Mild Persistent Asthma | 06/14 | 01/15 | | |
| Completed | 2 | 42 | Europe, Canada, US | Placebo, Dupilumab SAR231893/REGN668, fluticasone propionate and salmeterol, Advair, budesonide and formoterol, Symbicort, mometasone furoate and formoterol, Dulera | Sanofi, Regeneron Pharmaceuticals | Asthma | 01/18 | 01/18 | | |
|
